Short Description

sFlt-1/PlGF ratio is intended to be used with clinical judgement and other investigations to diagnose Pre-eclampsia in suspected cases. It may be used for testing pregnant women from 20 weeks gestation up until the time of delivery. Using sFlt-1/PlGF ratio in addition to standard clinical assessment could result in a faster and more accurate diagnosis of Pre-eclampsia, and better risk assessment for adverse outcomes. This assay if negative, helps to alleviate the need for unnecessary hospitalization in suspected Pre-eclampsia patients.

PreTest Information

No special preparation required

Detail Description

Pre-eclampsia Predictor (sFLT-1:PIGF Ratio) Panel Test

Pre-eclampsia is a pregnancy complication that affects around 5% of pregnant women worldwide. It is a potentially life-threatening condition that is characterized by high blood pressure and damage to organs, such as the kidneys and liver. Early detection and management of pre-eclampsia are crucial to prevent serious complications.

One of the latest developments in pre-eclampsia screening is the sFLT-1:PIGF ratio panel test. This test measures the levels of two proteins, sFLT-1 and PIGF, in the mother's blood. The ratio of these proteins can help predict the risk of developing pre-eclampsia.

Symptoms of Pre-eclampsia

Pre-eclampsia can develop after 20 weeks of pregnancy. Some of the common symptoms of pre-eclampsia include:

• High blood pressure
• Swelling in the hands and feet
• Protein in the urine
• Headaches
• Blurred vision
• Pain in the upper-right abdomen

If you experience any of these symptoms during pregnancy, it is important to seek medical attention immediately.

Diagnosis of Pre-eclampsia

Pre-eclampsia can only be diagnosed through a combination of blood pressure and urine tests. The sFLT-1:PIGF ratio panel test is a new tool that can help predict the risk of developing pre-eclampsia.

The sFLT-1:PIGF ratio panel test is a simple blood test that measures the levels of two proteins, sFLT-1 and PIGF, in the mother's blood. These proteins are produced by the placenta, and their levels can indicate the risk of pre-eclampsia.

Pre-eclampsia Predictor (sFLT-1:PIGF Ratio) Panel Test Cost

The cost of the pre-eclampsia predictor (sFLT-1:PIGF ratio) panel test in India is INR 4500. This cost may vary depending on the location and the laboratory where the test is performed.

Conclusion

The sFLT-1:PIGF ratio panel test is a new tool that can help predict the risk of developing pre-eclampsia during pregnancy. Early detection and management of pre-eclampsia can prevent serious complications for both the mother and the baby. If you experience any symptoms of pre-eclampsia during pregnancy, it is important to seek medical attention immediately.

At DNA Labs India, we offer a wide range of prenatal tests, including the pre-eclampsia predictor (sFLT-1:PIGF ratio) panel test. Contact us today to learn more about our services.

sFlt-1/PlGF ratio is intended to be used with clinical judgement and other investigations to diagnose Pre-eclampsia in suspected cases. It may be used for testing pregnant women from 20 weeks gestation up until the time of delivery. Using sFlt-1/PlGF ratio in addition to standard clinical assessment could result in a faster and more accurate diagnosis of Pre-eclampsia, and better risk assessment for adverse outcomes. This assay if negative, helps to alleviate the need for unnecessary hospitalization in suspected Pre-eclampsia patients.